世界のプロスタグランジンE2受容体EP2サブタイプ市場 2021：企業別、地域別、種類・用途別

• 英文タイトル：Global Prostaglandin E2 Receptor EP2 Subtype Market 2021 by Company, Regions, Type and Application, Forecast to 2026

• レポートコード：GIR-107A15075 • 出版社/出版日：GlobalInfoResearch / 2021年7月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、84ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥515,040 (USD3,480)	▷ お問い合わせ
Multi User	￥772,560 (USD5,220)	▷ お問い合わせ
Corporate User	￥1,030,080 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

当調査資料では、プロスタグランジンE2受容体EP2サブタイプのグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。プロスタグランジンE2受容体EP2サブタイプの種類別市場規模（TG-4155、SAR-366234、ONO-8055、トレプロスチニル、その他）、用途別市場規模（クリニック、病院、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・プロスタグランジンE2受容体EP2サブタイプの市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Amgen Inc.、Ascendis Pharma A/S、Ono Pharmaceutical Co., Ltd.、Sanofi、Santen Pharmaceutical Co., Ltd. ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：TG-4155、SAR-366234、ONO-8055、トレプロスチニル、その他 ・用途別分析2016年-2026年：クリニック、病院、その他 ・プロスタグランジンE2受容体EP2サブタイプの北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・プロスタグランジンE2受容体EP2サブタイプのヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・プロスタグランジンE2受容体EP2サブタイプのアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・プロスタグランジンE2受容体EP2サブタイプの南米市場規模2016年-2026年：ブラジル、アルゼンチン ・プロスタグランジンE2受容体EP2サブタイプの中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論

The Prostaglandin E2 Receptor EP2 Subtype market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Prostaglandin E2 Receptor EP2 Subtype size is estimated to be USD xx million in 2026 from USD xx million in 2020, with a change XX% between 2020 and 2021. The global Prostaglandin E2 Receptor EP2 Subtype market size is expected to grow at a CAGR of xx% for the next five years.

Market segmentation
Prostaglandin E2 Receptor EP2 Subtype market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
TG-4155
SAR-366234
ONO-8055
Treprostinil
Others

Market segment by Application, can be divided into
Clinic
Hospital
Others

Market segment by players, this report covers
Amgen Inc.
Ascendis Pharma A/S
Ono Pharmaceutical Co., Ltd.
Sanofi
Santen Pharmaceutical Co., Ltd.

Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Prostaglandin E2 Receptor EP2 Subtype product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Prostaglandin E2 Receptor EP2 Subtype, with revenue, gross margin and global market share of Prostaglandin E2 Receptor EP2 Subtype from 2019 to 2021.
Chapter 3, the Prostaglandin E2 Receptor EP2 Subtype competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by type and application, with revenue and growth rate by type, application, from 2016 to 2026.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2016 to 2021.and Prostaglandin E2 Receptor EP2 Subtype market forecast, by regions, type and application, with revenue, from 2021 to 2026.
Chapter 11 and 12, to describe Prostaglandin E2 Receptor EP2 Subtype research findings and conclusion, appendix and data source.

レポート目次

---

1 Market Overview
1.1 Product Overview and Scope of Prostaglandin E2 Receptor EP2 Subtype
1.2 Classification of Prostaglandin E2 Receptor EP2 Subtype by Type
1.2.1 Overview: Global Prostaglandin E2 Receptor EP2 Subtype Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Prostaglandin E2 Receptor EP2 Subtype Revenue Market Share by Type in 2020
1.2.3 TG-4155
1.2.4 SAR-366234
1.2.5 ONO-8055
1.2.6 Treprostinil
1.2.7 Others
1.3 Global Prostaglandin E2 Receptor EP2 Subtype Market by Application
1.3.1 Overview: Global Prostaglandin E2 Receptor EP2 Subtype Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Clinic
1.3.3 Hospital
1.3.4 Others
1.4 Global Prostaglandin E2 Receptor EP2 Subtype Market Size & Forecast
1.5 Global Prostaglandin E2 Receptor EP2 Subtype Market Size and Forecast by Region
1.5.1 Global Prostaglandin E2 Receptor EP2 Subtype Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Prostaglandin E2 Receptor EP2 Subtype Market Size by Region, (2016-2021)
1.5.3 North America Prostaglandin E2 Receptor EP2 Subtype Market Size and Prospect (2016-2026)
1.5.4 Europe Prostaglandin E2 Receptor EP2 Subtype Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Prostaglandin E2 Receptor EP2 Subtype Market Size and Prospect (2016-2026)
1.5.6 South America Prostaglandin E2 Receptor EP2 Subtype Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Prostaglandin E2 Receptor EP2 Subtype Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Prostaglandin E2 Receptor EP2 Subtype Market Drivers
1.6.2 Prostaglandin E2 Receptor EP2 Subtype Market Restraints
1.6.3 Prostaglandin E2 Receptor EP2 Subtype Trends Analysis
2 Company Profiles
2.1 Amgen Inc.
2.1.1 Amgen Inc. Details
2.1.2 Amgen Inc. Major Business
2.1.3 Amgen Inc. Prostaglandin E2 Receptor EP2 Subtype Product and Solutions
2.1.4 Amgen Inc. Prostaglandin E2 Receptor EP2 Subtype Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Amgen Inc. Recent Developments and Future Plans
2.2 Ascendis Pharma A/S
2.2.1 Ascendis Pharma A/S Details
2.2.2 Ascendis Pharma A/S Major Business
2.2.3 Ascendis Pharma A/S Prostaglandin E2 Receptor EP2 Subtype Product and Solutions
2.2.4 Ascendis Pharma A/S Prostaglandin E2 Receptor EP2 Subtype Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Ascendis Pharma A/S Recent Developments and Future Plans
2.3 Ono Pharmaceutical Co., Ltd.
2.3.1 Ono Pharmaceutical Co., Ltd. Details
2.3.2 Ono Pharmaceutical Co., Ltd. Major Business
2.3.3 Ono Pharmaceutical Co., Ltd. Prostaglandin E2 Receptor EP2 Subtype Product and Solutions
2.3.4 Ono Pharmaceutical Co., Ltd. Prostaglandin E2 Receptor EP2 Subtype Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Ono Pharmaceutical Co., Ltd. Recent Developments and Future Plans
2.4 Sanofi
2.4.1 Sanofi Details
2.4.2 Sanofi Major Business
2.4.3 Sanofi Prostaglandin E2 Receptor EP2 Subtype Product and Solutions
2.4.4 Sanofi Prostaglandin E2 Receptor EP2 Subtype Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Sanofi Recent Developments and Future Plans
2.5 Santen Pharmaceutical Co., Ltd.
2.5.1 Santen Pharmaceutical Co., Ltd. Details
2.5.2 Santen Pharmaceutical Co., Ltd. Major Business
2.5.3 Santen Pharmaceutical Co., Ltd. Prostaglandin E2 Receptor EP2 Subtype Product and Solutions
2.5.4 Santen Pharmaceutical Co., Ltd. Prostaglandin E2 Receptor EP2 Subtype Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Santen Pharmaceutical Co., Ltd. Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Prostaglandin E2 Receptor EP2 Subtype Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 Prostaglandin E2 Receptor EP2 Subtype Players Market Share
3.2.2 Top 10 Prostaglandin E2 Receptor EP2 Subtype Players Market Share
3.2.3 Market Competition Trend
3.3 Prostaglandin E2 Receptor EP2 Subtype Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Prostaglandin E2 Receptor EP2 Subtype Revenue and Market Share by Type (2016-2021)
4.2 Global Prostaglandin E2 Receptor EP2 Subtype Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Prostaglandin E2 Receptor EP2 Subtype Revenue Market Share by Application (2016-2021)
5.2 Prostaglandin E2 Receptor EP2 Subtype Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Prostaglandin E2 Receptor EP2 Subtype Revenue by Type (2016-2026)
6.2 North America Prostaglandin E2 Receptor EP2 Subtype Revenue by Application (2016-2026)
6.3 North America Prostaglandin E2 Receptor EP2 Subtype Market Size by Country
6.3.1 North America Prostaglandin E2 Receptor EP2 Subtype Revenue by Country (2016-2026)
6.3.2 United States Prostaglandin E2 Receptor EP2 Subtype Market Size and Forecast (2016-2026)
6.3.3 Canada Prostaglandin E2 Receptor EP2 Subtype Market Size and Forecast (2016-2026)
6.3.4 Mexico Prostaglandin E2 Receptor EP2 Subtype Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Prostaglandin E2 Receptor EP2 Subtype Revenue by Type (2016-2026)
7.2 Europe Prostaglandin E2 Receptor EP2 Subtype Revenue by Application (2016-2026)
7.3 Europe Prostaglandin E2 Receptor EP2 Subtype Market Size by Country
7.3.1 Europe Prostaglandin E2 Receptor EP2 Subtype Revenue by Country (2016-2026)
7.3.2 Germany Prostaglandin E2 Receptor EP2 Subtype Market Size and Forecast (2016-2026)
7.3.3 France Prostaglandin E2 Receptor EP2 Subtype Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Prostaglandin E2 Receptor EP2 Subtype Market Size and Forecast (2016-2026)
7.3.5 Russia Prostaglandin E2 Receptor EP2 Subtype Market Size and Forecast (2016-2026)
7.3.6 Italy Prostaglandin E2 Receptor EP2 Subtype Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Prostaglandin E2 Receptor EP2 Subtype Revenue by Type (2016-2026)
8.2 Asia-Pacific Prostaglandin E2 Receptor EP2 Subtype Revenue by Application (2016-2026)
8.3 Asia-Pacific Prostaglandin E2 Receptor EP2 Subtype Market Size by Region
8.3.1 Asia-Pacific Prostaglandin E2 Receptor EP2 Subtype Revenue by Region (2016-2026)
8.3.2 China Prostaglandin E2 Receptor EP2 Subtype Market Size and Forecast (2016-2026)
8.3.3 Japan Prostaglandin E2 Receptor EP2 Subtype Market Size and Forecast (2016-2026)
8.3.4 South Korea Prostaglandin E2 Receptor EP2 Subtype Market Size and Forecast (2016-2026)
8.3.5 India Prostaglandin E2 Receptor EP2 Subtype Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Prostaglandin E2 Receptor EP2 Subtype Market Size and Forecast (2016-2026)
8.3.7 Australia Prostaglandin E2 Receptor EP2 Subtype Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Prostaglandin E2 Receptor EP2 Subtype Revenue by Type (2016-2026)
9.2 South America Prostaglandin E2 Receptor EP2 Subtype Revenue by Application (2016-2026)
9.3 South America Prostaglandin E2 Receptor EP2 Subtype Market Size by Country
9.3.1 South America Prostaglandin E2 Receptor EP2 Subtype Revenue by Country (2016-2026)
9.3.2 Brazil Prostaglandin E2 Receptor EP2 Subtype Market Size and Forecast (2016-2026)
9.3.3 Argentina Prostaglandin E2 Receptor EP2 Subtype Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Prostaglandin E2 Receptor EP2 Subtype Revenue by Type (2016-2026)
10.2 Middle East & Africa Prostaglandin E2 Receptor EP2 Subtype Revenue by Application (2016-2026)
10.3 Middle East & Africa Prostaglandin E2 Receptor EP2 Subtype Market Size by Country
10.3.1 Middle East & Africa Prostaglandin E2 Receptor EP2 Subtype Revenue by Country (2016-2026)
10.3.2 Turkey Prostaglandin E2 Receptor EP2 Subtype Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Prostaglandin E2 Receptor EP2 Subtype Market Size and Forecast (2016-2026)
10.3.4 UAE Prostaglandin E2 Receptor EP2 Subtype Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer

List of Tables
Table 1. Global Prostaglandin E2 Receptor EP2 Subtype Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Prostaglandin E2 Receptor EP2 Subtype Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Prostaglandin E2 Receptor EP2 Subtype Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Prostaglandin E2 Receptor EP2 Subtype Revenue (USD Million) by Region (2016-2021)
Table 5. Global Prostaglandin E2 Receptor EP2 Subtype Revenue Market Share by Region (2021-2026)
Table 6. Amgen Inc. Corporate Information, Head Office, and Major Competitors
Table 7. Amgen Inc. Major Business
Table 8. Amgen Inc. Prostaglandin E2 Receptor EP2 Subtype Product and Solutions
Table 9. Amgen Inc. Prostaglandin E2 Receptor EP2 Subtype Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Ascendis Pharma A/S Corporate Information, Head Office, and Major Competitors
Table 11. Ascendis Pharma A/S Major Business
Table 12. Ascendis Pharma A/S Prostaglandin E2 Receptor EP2 Subtype Product and Solutions
Table 13. Ascendis Pharma A/S Prostaglandin E2 Receptor EP2 Subtype Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Ono Pharmaceutical Co., Ltd. Corporate Information, Head Office, and Major Competitors
Table 15. Ono Pharmaceutical Co., Ltd. Major Business
Table 16. Ono Pharmaceutical Co., Ltd. Prostaglandin E2 Receptor EP2 Subtype Product and Solutions
Table 17. Ono Pharmaceutical Co., Ltd. Prostaglandin E2 Receptor EP2 Subtype Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Sanofi Corporate Information, Head Office, and Major Competitors
Table 19. Sanofi Major Business
Table 20. Sanofi Prostaglandin E2 Receptor EP2 Subtype Product and Solutions
Table 21. Sanofi Prostaglandin E2 Receptor EP2 Subtype Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Santen Pharmaceutical Co., Ltd. Corporate Information, Head Office, and Major Competitors
Table 23. Santen Pharmaceutical Co., Ltd. Major Business
Table 24. Santen Pharmaceutical Co., Ltd. Prostaglandin E2 Receptor EP2 Subtype Product and Solutions
Table 25. Santen Pharmaceutical Co., Ltd. Prostaglandin E2 Receptor EP2 Subtype Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. Global Prostaglandin E2 Receptor EP2 Subtype Revenue (USD Million) by Players (2019-2021)
Table 27. Global Prostaglandin E2 Receptor EP2 Subtype Revenue Share by Players (2019-2021)
Table 28. Breakdown of Prostaglandin E2 Receptor EP2 Subtype by Company Type (Tier 1, Tier 2 and Tier 3)
Table 29. Prostaglandin E2 Receptor EP2 Subtype Players Head Office, Products and Services Provided
Table 30. Prostaglandin E2 Receptor EP2 Subtype Mergers & Acquisitions in the Past Five Years
Table 31. Prostaglandin E2 Receptor EP2 Subtype New Entrants and Expansion Plans
Table 32. Global Prostaglandin E2 Receptor EP2 Subtype Revenue (USD Million) by Type (2016-2021)
Table 33. Global Prostaglandin E2 Receptor EP2 Subtype Revenue Share by Type (2016-2021)
Table 34. Global Prostaglandin E2 Receptor EP2 Subtype Revenue Forecast by Type (2021-2026)
Table 35. Global Prostaglandin E2 Receptor EP2 Subtype Revenue by Application (2016-2021)
Table 36. Global Prostaglandin E2 Receptor EP2 Subtype Revenue Forecast by Application (2021-2026)
Table 37. North America Prostaglandin E2 Receptor EP2 Subtype Revenue by Type (2016-2021) & (USD Million)
Table 38. North America Prostaglandin E2 Receptor EP2 Subtype Revenue by Type (2021-2026) & (USD Million)
Table 39. North America Prostaglandin E2 Receptor EP2 Subtype Revenue by Application (2016-2021) & (USD Million)
Table 40. North America Prostaglandin E2 Receptor EP2 Subtype Revenue by Application (2021-2026) & (USD Million)
Table 41. North America Prostaglandin E2 Receptor EP2 Subtype Revenue by Country (2016-2021) & (USD Million)
Table 42. North America Prostaglandin E2 Receptor EP2 Subtype Revenue by Country (2021-2026) & (USD Million)
Table 43. Europe Prostaglandin E2 Receptor EP2 Subtype Revenue by Type (2016-2021) & (USD Million)
Table 44. Europe Prostaglandin E2 Receptor EP2 Subtype Revenue by Type (2021-2026) & (USD Million)
Table 45. Europe Prostaglandin E2 Receptor EP2 Subtype Revenue by Application (2016-2021) & (USD Million)
Table 46. Europe Prostaglandin E2 Receptor EP2 Subtype Revenue by Application (2021-2026) & (USD Million)
Table 47. Europe Prostaglandin E2 Receptor EP2 Subtype Revenue by Country (2016-2021) & (USD Million)
Table 48. Europe Prostaglandin E2 Receptor EP2 Subtype Revenue by Country (2021-2026) & (USD Million)
Table 49. Asia-Pacific Prostaglandin E2 Receptor EP2 Subtype Revenue by Type (2016-2021) & (USD Million)
Table 50. Asia-Pacific Prostaglandin E2 Receptor EP2 Subtype Revenue by Type (2021-2026) & (USD Million)
Table 51. Asia-Pacific Prostaglandin E2 Receptor EP2 Subtype Revenue by Application (2016-2021) & (USD Million)
Table 52. Asia-Pacific Prostaglandin E2 Receptor EP2 Subtype Revenue by Application (2021-2026) & (USD Million)
Table 53. Asia-Pacific Prostaglandin E2 Receptor EP2 Subtype Revenue by Region (2016-2021) & (USD Million)
Table 54. Asia-Pacific Prostaglandin E2 Receptor EP2 Subtype Revenue by Region (2021-2026) & (USD Million)
Table 55. South America Prostaglandin E2 Receptor EP2 Subtype Revenue by Type (2016-2021) & (USD Million)
Table 56. South America Prostaglandin E2 Receptor EP2 Subtype Revenue by Type (2021-2026) & (USD Million)
Table 57. South America Prostaglandin E2 Receptor EP2 Subtype Revenue by Application (2016-2021) & (USD Million)
Table 58. South America Prostaglandin E2 Receptor EP2 Subtype Revenue by Application (2021-2026) & (USD Million)
Table 59. South America Prostaglandin E2 Receptor EP2 Subtype Revenue by Country (2016-2021) & (USD Million)
Table 60. South America Prostaglandin E2 Receptor EP2 Subtype Revenue by Country (2021-2026) & (USD Million)
Table 61. Middle East & Africa Prostaglandin E2 Receptor EP2 Subtype Revenue by Type (2016-2021) & (USD Million)
Table 62. Middle East & Africa Prostaglandin E2 Receptor EP2 Subtype Revenue by Type (2021-2026) & (USD Million)
Table 63. Middle East & Africa Prostaglandin E2 Receptor EP2 Subtype Revenue by Application (2016-2021) & (USD Million)
Table 64. Middle East & Africa Prostaglandin E2 Receptor EP2 Subtype Revenue by Application (2021-2026) & (USD Million)
Table 65. Middle East & Africa Prostaglandin E2 Receptor EP2 Subtype Revenue by Country (2016-2021) & (USD Million)
Table 66. Middle East & Africa Prostaglandin E2 Receptor EP2 Subtype Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Prostaglandin E2 Receptor EP2 Subtype Picture
Figure 2. Global Prostaglandin E2 Receptor EP2 Subtype Revenue Market Share by Type in 2020
Figure 3. TG-4155
Figure 4. SAR-366234
Figure 5. ONO-8055
Figure 6. Treprostinil
Figure 7. Others
Figure 8. Prostaglandin E2 Receptor EP2 Subtype Revenue Market Share by Application in 2020
Figure 9. Clinic Picture
Figure 10. Hospital Picture
Figure 11. Others Picture
Figure 12. Global Prostaglandin E2 Receptor EP2 Subtype Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 13. Global Prostaglandin E2 Receptor EP2 Subtype Revenue and Forecast (2016-2026) & (USD Million)
Figure 14. Global Prostaglandin E2 Receptor EP2 Subtype Revenue Market Share by Region (2016-2026)
Figure 15. Global Prostaglandin E2 Receptor EP2 Subtype Revenue Market Share by Region in 2020
Figure 16. North America Prostaglandin E2 Receptor EP2 Subtype Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. Europe Prostaglandin E2 Receptor EP2 Subtype Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. Asia-Pacific Prostaglandin E2 Receptor EP2 Subtype Revenue (USD Million) and Growth Rate (2016-2026)
Figure 19. South America Prostaglandin E2 Receptor EP2 Subtype Revenue (USD Million) and Growth Rate (2016-2026)
Figure 20. Middle East and Africa Prostaglandin E2 Receptor EP2 Subtype Revenue (USD Million) and Growth Rate (2016-2026)
Figure 21. Prostaglandin E2 Receptor EP2 Subtype Market Drivers
Figure 22. Prostaglandin E2 Receptor EP2 Subtype Market Restraints
Figure 23. Prostaglandin E2 Receptor EP2 Subtype Market Trends
Figure 24. Amgen Inc. Recent Developments and Future Plans
Figure 25. Ascendis Pharma A/S Recent Developments and Future Plans
Figure 26. Ono Pharmaceutical Co., Ltd. Recent Developments and Future Plans
Figure 27. Sanofi Recent Developments and Future Plans
Figure 28. Santen Pharmaceutical Co., Ltd. Recent Developments and Future Plans
Figure 29. Global Prostaglandin E2 Receptor EP2 Subtype Revenue Share by Players in 2020
Figure 30. Prostaglandin E2 Receptor EP2 Subtype Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 31. Global Top 3 Players Prostaglandin E2 Receptor EP2 Subtype Revenue Market Share in 2020
Figure 32. Global Top 10 Players Prostaglandin E2 Receptor EP2 Subtype Revenue Market Share in 2020
Figure 33. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 34. Global Prostaglandin E2 Receptor EP2 Subtype Revenue Share by Type in 2020
Figure 35. Global Prostaglandin E2 Receptor EP2 Subtype Market Share Forecast by Type (2021-2026)
Figure 36. Global Prostaglandin E2 Receptor EP2 Subtype Revenue Share by Application in 2020
Figure 37. Global Prostaglandin E2 Receptor EP2 Subtype Market Share Forecast by Application (2021-2026)
Figure 38. North America Prostaglandin E2 Receptor EP2 Subtype Sales Market Share by Type (2016-2026)
Figure 39. North America Prostaglandin E2 Receptor EP2 Subtype Sales Market Share by Application (2016-2026)
Figure 40. North America Prostaglandin E2 Receptor EP2 Subtype Revenue Market Share by Country (2016-2026)
Figure 41. United States Prostaglandin E2 Receptor EP2 Subtype Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 42. Canada Prostaglandin E2 Receptor EP2 Subtype Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 43. Mexico Prostaglandin E2 Receptor EP2 Subtype Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 44. Europe Prostaglandin E2 Receptor EP2 Subtype Sales Market Share by Type (2016-2026)
Figure 45. Europe Prostaglandin E2 Receptor EP2 Subtype Sales Market Share by Application (2016-2026)
Figure 46. Europe Prostaglandin E2 Receptor EP2 Subtype Revenue Market Share by Country (2016-2026)
Figure 47. Germany Prostaglandin E2 Receptor EP2 Subtype Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 48. France Prostaglandin E2 Receptor EP2 Subtype Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 49. United Kingdom Prostaglandin E2 Receptor EP2 Subtype Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 50. Russia Prostaglandin E2 Receptor EP2 Subtype Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. Italy Prostaglandin E2 Receptor EP2 Subtype Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. Asia-Pacific Prostaglandin E2 Receptor EP2 Subtype Sales Market Share by Type (2016-2026)
Figure 53. Asia-Pacific Prostaglandin E2 Receptor EP2 Subtype Sales Market Share by Application (2016-2026)
Figure 54. Asia-Pacific Prostaglandin E2 Receptor EP2 Subtype Revenue Market Share by Region (2016-2026)
Figure 55. China Prostaglandin E2 Receptor EP2 Subtype Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. Japan Prostaglandin E2 Receptor EP2 Subtype Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. South Korea Prostaglandin E2 Receptor EP2 Subtype Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. India Prostaglandin E2 Receptor EP2 Subtype Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. Southeast Asia Prostaglandin E2 Receptor EP2 Subtype Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. Australia Prostaglandin E2 Receptor EP2 Subtype Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. South America Prostaglandin E2 Receptor EP2 Subtype Sales Market Share by Type (2016-2026)
Figure 62. South America Prostaglandin E2 Receptor EP2 Subtype Sales Market Share by Application (2016-2026)
Figure 63. South America Prostaglandin E2 Receptor EP2 Subtype Revenue Market Share by Country (2016-2026)
Figure 64. Brazil Prostaglandin E2 Receptor EP2 Subtype Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. Argentina Prostaglandin E2 Receptor EP2 Subtype Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. Middle East and Africa Prostaglandin E2 Receptor EP2 Subtype Sales Market Share by Type (2016-2026)
Figure 67. Middle East and Africa Prostaglandin E2 Receptor EP2 Subtype Sales Market Share by Application (2016-2026)
Figure 68. Middle East and Africa Prostaglandin E2 Receptor EP2 Subtype Revenue Market Share by Country (2016-2026)
Figure 69. Turkey Prostaglandin E2 Receptor EP2 Subtype Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 70. Saudi Arabia Prostaglandin E2 Receptor EP2 Subtype Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 71. UAE Prostaglandin E2 Receptor EP2 Subtype Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 72. Methodology
Figure 73. Research Process and Data Source

---